All Blogs & News

In this issue: New study reports the economic impact of a delayed diagnosis is up to $517,000 in avoidable costs per patient in rare disease

In this issue: What is Ataluren and what does recent research show about its potential use in treating individuals with SDS in the...

In this issue: New research contributes to knowledge on how we can improve bone marrow failure surveillance in SDS Welcome to our timely...